Customise results display
Results 1-6 of 6 (Search time: 0.004 seconds).
|1-Jan-2016||Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma||Tayao, M; Andrici, J; Farzin, M; Clarkson, A; Sioson, L; Watson, N; Chua, TC; Sztynda, T; Samra, JS; Gill, AJ|
|1-Feb-2012||A single nucleotide polymorphism in EXO1 gene is associated with cervical cancer susceptibility in chinese patients||Luo, X; Hong, XS; Xiong, XD; Zeng, LQ; Lim, CED|
|20-Jul-1998||In vivo gene therapy for prostate cancer: Preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors||Martiniello-Wilks, R; Garcia-Aragon, J; Daja, MM; Russell, P; Both, GW; Molloy, PL; Lockett, LJ; Russell, PJ|
|1-Jan-2012||Microparticle-associated nucleic acids mediate trait dominance in cancer||Jaiswal, R; Gong, J; Sambasivam, S; Combes, V; Mathys, JM; Davey, R; Grau, GER; Bebawy, M|
|1-Nov-2018||Clinical relevance of the multidrug resistance-associated protein 1 gene in non-small cell lung cancer: A systematic review and meta-analysis||Hu, P; Ting-Yat Wong, P; Zhou, Q; Sheng, L; Niu, W; Chen, S; Xu, M; Lin, Y|
|1-Jan-2004||Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease||Martiniello-Wilks, R; Dane, A; Voeks, DJ; Jeyakumar, G; Mortensen, E; Shaw, JM; Wang, XY; Both, GW; Russell, PJ|